Literature DB >> 26212402

Psychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury.

Flora M Hammond1, Ryan S Barrett2, Timothy Shea3, Ronald T Seel4, Thomas W McAlister5, Darryl Kaelin6, David K Ryser7, John D Corrigan3, Nora Cullen8, Susan D Horn2.   

Abstract

OBJECTIVE: To describe psychotropic medication administration patterns during inpatient rehabilitation for traumatic brain injury (TBI) and their relation to patient preinjury and injury characteristics.
DESIGN: Prospective observational cohort.
SETTING: Multiple acute inpatient rehabilitation units or hospitals. PARTICIPANTS: Individuals with TBI (N=2130; complicated mild, moderate, or severe) admitted for inpatient rehabilitation.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Not applicable.
RESULTS: Most frequently administered were narcotic analgesics (72% of sample), followed by antidepressants (67%), anticonvulsants (47%), anxiolytics (33%), hypnotics (30%), stimulants (28%), antipsychotics (25%), antiparkinson agents (25%), and miscellaneous psychotropics (18%). The psychotropic agents studied were administered to 95% of the sample, with 8.5% receiving only 1 and 31.8% receiving ≥6. Degree of psychotropic medication administration varied widely between sites. Univariate analyses indicated younger patients were more likely to receive anxiolytics, antidepressants, antiparkinson agents, stimulants, antipsychotics, and narcotic analgesics, whereas those older were more likely to receive anticonvulsants and miscellaneous psychotropics. Men were more likely to receive antipsychotics. All medication classes were less likely administered to Asians and more likely administered to those with more severe functional impairment. Use of anticonvulsants was associated with having seizures at some point during acute care or rehabilitation stays. Narcotic analgesics were more likely for those with history of drug abuse, history of anxiety and depression (premorbid or during acute care), and severe pain during rehabilitation. Psychotropic medication administration increased rather than decreased during the course of inpatient rehabilitation in each of the medication categories except for narcotics. This observation was also true for medication administration within admission functional levels (defined by cognitive FIM scores), except for those with higher admission FIM cognitive scores.
CONCLUSIONS: Many psychotropic medications are used during inpatient rehabilitation. In general, lower admission FIM cognitive score groups were administered more of the medications under investigation compared with those with higher cognitive function at admission. Considerable site variation existed regarding medications administered. The current investigation provides baseline data for future studies of effectiveness.
Copyright © 2015 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amantadine; Antidepressive agents; Antipsychotic agents; Brain injuries; Central nervous system stimulants; Drug therapy; Medication therapy management; Patient care; Physician's practice patterns; Polypharmacy; Rehabilitation

Mesh:

Substances:

Year:  2015        PMID: 26212402      PMCID: PMC4516906          DOI: 10.1016/j.apmr.2015.01.025

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  24 in total

1.  Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment.

Authors:  Andrew C Leon; Donald Hedeker; Jedediah J Teres
Journal:  Stat Med       Date:  2007-01-15       Impact factor: 2.373

2.  SSRI-associated sexual dysfunction.

Authors:  Richard Balon
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

3.  The impact of acute care medications on rehabilitation outcome after traumatic brain injury.

Authors:  W Jerry Mysiw; Jennifer A Bogner; John D Corrigan; Lisa P Fugate; Daniel M Clinchot; Vivek Kadyan
Journal:  Brain Inj       Date:  2006-08       Impact factor: 2.311

4.  A comparison of mixed-effects quantile stratification propensity adjustment strategies for longitudinal treatment effectiveness analyses of continuous outcomes.

Authors:  Andrew C Leon; Donald Hedeker
Journal:  Stat Med       Date:  2007-06-15       Impact factor: 2.373

5.  Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation.

Authors:  L P Fugate; L A Spacek; L A Kresty; C E Levy; J C Johnson; W J Mysiw
Journal:  Arch Phys Med Rehabil       Date:  1997-09       Impact factor: 3.966

6.  Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury.

Authors:  Deborah L Warden; Barry Gordon; Thomas W McAllister; Jonathan M Silver; Jeffery T Barth; John Bruns; Angela Drake; Tony Gentry; Andy Jagoda; Douglas I Katz; Jess Kraus; Lawrence A Labbate; Laurie M Ryan; Molly B Sparling; Beverly Walters; John Whyte; Ashley Zapata; George Zitnay
Journal:  J Neurotrauma       Date:  2006-10       Impact factor: 5.269

7.  Measuring medical complexity during inpatient rehabilitation after traumatic brain injury.

Authors:  David K Ryser; Marlene J Egger; Susan D Horn; Diana Handrahan; Partha Gandhi; Erin D Bigler
Journal:  Arch Phys Med Rehabil       Date:  2005-06       Impact factor: 3.966

Review 8.  Use of methylphenidate in traumatic brain injury.

Authors:  O'Rita M Siddall
Journal:  Ann Pharmacother       Date:  2005-05-24       Impact factor: 3.154

9.  Pharmacological management of neurobehavioural sequelae of traumatic brain injury: a survey of current physiatric practice.

Authors:  Gerard E Francisco; William C Walker; Nathan D Zasler; Mark H Bouffard
Journal:  Brain Inj       Date:  2007-09       Impact factor: 2.311

10.  Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.

Authors:  P M Plenger; C E Dixon; R M Castillo; R F Frankowski; S A Yablon; H S Levin
Journal:  Arch Phys Med Rehabil       Date:  1996-06       Impact factor: 3.966

View more
  18 in total

Review 1.  The intersection of lifetime history of traumatic brain injury and the opioid epidemic.

Authors:  John D Corrigan; Rachel Sayko Adams
Journal:  Addict Behav       Date:  2018-10-29       Impact factor: 3.913

2.  Opioid Use among Individuals with Traumatic Brain Injury: A Perfect Storm?

Authors:  Rachel Sayko Adams; John D Corrigan; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2019-08-16       Impact factor: 5.269

3.  Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial.

Authors:  Jesse R Fann; Charles H Bombardier; Nancy Temkin; Peter Esselman; Catherine Warms; Jason Barber; Sureyya Dikmen
Journal:  J Head Trauma Rehabil       Date:  2017 Sep/Oct       Impact factor: 2.710

4.  Mortality Secondary to Unintentional Poisoning after Inpatient Rehabilitation among Individuals with Moderate to Severe Traumatic Brain Injury.

Authors:  Flora M Hammond; Jessica Ketchum; Kristen Dams-O'Connor; John D Corrigan; Cate Miller; Juliet Haarbauer-Krupa; Mark Faul; Lance E Trexler; Cynthia Harrison-Felix
Journal:  J Neurotrauma       Date:  2020-07-08       Impact factor: 5.269

Review 5.  Scoping Review of Opioid Use After Traumatic Brain Injury.

Authors:  Amy J Starosta; Rachel Sayko Adams; Jennifer H Marwitz; Jeffrey Kreutzer; Kimberley R Monden; Kristen Dams O'Connor; Jeanne Hoffman
Journal:  J Head Trauma Rehabil       Date:  2021 Sep-Oct 01       Impact factor: 3.117

6.  Evaluation of Outcomes in Patients Receiving Amantadine to Improve Alertness After Traumatic Brain Injury.

Authors:  Rim M Hadgu; Amne Borghol; Christopher Gillard; Candice Wilson; Suzan Elqess Mossa; Megan McKay; Charles Jastram; Ifeanyi O Onor
Journal:  Hosp Pharm       Date:  2020-05-17

7.  Traumatic Brain Injury Patient, Injury, Therapy, and Ancillary Treatments Associated With Outcomes at Discharge and 9 Months Postdischarge.

Authors:  Susan D Horn; John D Corrigan; Cynthia L Beaulieu; Jennifer Bogner; Ryan S Barrett; Clare G Giuffrida; David K Ryser; Kelli Cooper; Deborah M Carroll; Daniel Deutscher
Journal:  Arch Phys Med Rehabil       Date:  2015-08       Impact factor: 3.966

8.  Concordance between current American Academy of Sleep Medicine and Centers for Medicare and Medicare scoring criteria for obstructive sleep apnea in hospitalized persons with traumatic brain injury: a VA TBI Model System study.

Authors:  Risa Nakase-Richardson; Marie N Dahdah; Emily Almeida; Peter Ricketti; Marc A Silva; Karel Calero; Ulysses Magalang; Daniel J Schwartz
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

9.  The prevalence and determinants of inappropriate sexual behaviour in people with acquired brain injury in nursing homes.

Authors:  Roy F Kohnen; Jan Lavrijsen; Reinier Akkermans; Debby Gerritsen; Raymond Koopmans
Journal:  J Adv Nurs       Date:  2021-02-25       Impact factor: 3.187

10.  Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis.

Authors:  David R Williamson; Anne Julie Frenette; Lisa Burry; Marc M Perreault; Emmanuel Charbonney; François Lamontagne; Marie-Julie Potvin; Jean-François Giguère; Sangeeta Mehta; Francis Bernard
Journal:  Syst Rev       Date:  2016-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.